Real-time enrollment status for this breast cancer triple negative clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:06 AM UTC
| NCT Number | NCT05877859 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer Triple Negative |
| Phase | Clinical Trial |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | May 7, 2026 (May 7, 2026) |
As of July 18, 2026: Clinical trial NCT05877859 is currently recruiting participants. This clinical trial study for breast cancer triple negative is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05877859 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05877859 was last updated May 7, 2026 (May 7, 2026). HelloStudys verifies this status automatically.